Melinda Pruis

Melinda Pruis

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.

Back to news

More news

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

10-08-2022

Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …

Take a virtual tour of our laboratory: from the biopsy to the patient report

Take a virtual tour of our laboratory: from the biopsy to the patient report

26-01-2021

What happens to your tumor tissue and blood during a comprehensive DNA test? What exactly does all the complex equipment …

Patients can benefit from whole genome sequencing for immunotherapy

Patients can benefit from whole genome sequencing for immunotherapy

01-10-2020

Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl